Skip to content
OpenCapital
Get started

MiMedx Group MDXG Balance Sheet Statement

Income StatementBalance SheetCash FlowRatiosSegments
QuarterlyAnnualTTM
YoY
SimplifiedDetailed
FY'25FY'24FY'23FY'22
Cash and cash equivalents
$166.12M+59.1%$104.42M+27.3%$82M+24.3%$65.95M-24.3%
Accounts receivable, net
$307.35M+32.4%$232.11M+11.6%$208.05M+21.2%$171.72M+13.3%
Inventories
$25.34M+6.4%$23.81M+13.3%$21.02M+59.5%$13.18M+15.8%
Raw materials
$1.22M+20.9%$1.01M+22.4%$825K+1.9%$810K+123%
Work in process
$8.67M+1.0%$8.58M+0.7%$8.52M+24.3%$6.86M+12.2%
Finished goods
$15.45M+8.7%$14.22M+21.8%$11.68M+112%$5.52M+12.3%
Prepaid expenses and other current assets
$10.3M+31.5%$7.84M+39.3%$5.62M-23.1%$7.32M+19.0%
Total current assets
$277.47M+44.6%$191.89M+16.8%$164.26M+22.4%$134.2M-9.6%
Property and equipment, net
$4.71M-20.7%$5.94M-14.8%$6.97M-11.2%$7.86M-14.3%
Accumulated depreciation
$23.5M+10.2%$21.32M+6.5%$20.03M-44.3%$35.93M+9.3%
Total property and equipment, gross
$28.21M+3.5%$27.27M+1.0%$27M-38.3%$43.78M+4.1%
Goodwill
$19.44M0.0%$19.44M0.0%$19.44M0.0%$19.44M0.0%
Intangible assets, net
$13.12M+12.8%$11.63M+121%$5.26M-10.2%$5.85M+8.7%
Deferred tax assets
$96.33M-26.5%$131.13M+222%$40.78M—$0—
Other non-current assets
$7.27M+8.4%$6.71M+3,174%$205K+38.5%$148K-20.4%
Total assets
$342.65M+29.8%$263.92M+10.4%$239.05M+39.4%$171.43M-8.8%
Accounts payable
$14.53M+96.1%$7.41M-18.1%$9.05M+7.0%$8.45M+14.5%
Accrued expenses
$31.07M+31.3%$23.67M+5.9%$22.35M+7.2%$20.86M-11.6%
Current portion of long-term debt
$1.5M+50.0%$1M0.0%$1M———
Total current liabilities
$64.27M+40.9%$45.6M-0.9%$46.01M+5.6%$43.56M+2.8%
Long-term debt
$16.47M-7.6%$17.83M-62.9%$48.1M-1.0%$48.59M+1.0%
Other non-current liabilities
$5.37M-27.2%$7.38M+232%$2.22M-53.4%$4.77M-2.0%
Total liabilities
$86.11M+21.6%$70.81M-26.5%$96.33M-0.6%$96.92M+1.6%
Common stock
250M+169,968%147K-99.9%250M+219,198%114K+0.9%
Additional paid-in capital
$299.08M+5.2%$284.22M+2.9%$276.25M+58.9%$173.8M+4.9%
Retained earnings
-$42.68M+53.2%-$91.26M+31.7%-$133.68M+30.3%-$191.91M-18.7%
Total stockholders' equity
$256.55M+32.9%$193.11M+35.3%$142.72M+893%-$17.99M-22,037%
Total liabilities and stockholders' equity
$342.65M+29.8%$263.92M+10.4%$239.05M+39.4%$171.43M-8.8%
Allowance for Doubtful Accounts Receivable (Current)
$8.7M+178%$3.13M-0.4%$3.14M-16.9%$3.78M+219%
Finished goods
$15.45M+8.7%$14.22M+21.8%$11.68M+112%$5.52M+12.3%
Other current assets
$10.3M+31.5%$7.84M+349%$1.75M-47.7%$3.34M+18.7%
Deferred Tax Assets and Other Non-Current Assets
$7.27M+8.4%$6.71M+3,174%$205K+38.5%$148K-20.4%
Finite Lived Intangible Assets - Gross
$37.32M+70.3%$21.92M+98.5%$11.04M+1.1%$10.92M—
Intangible Assets Gross (Excluding Goodwill)
$38.36M+65.3%$23.22M+76.8%$13.13M+1.3%$12.96M+9.9%
Deferred tax assets
$19.6M-30.8%$28.31M-30.6%$40.78M—$0—
Intangible assets — net
$13.12M+27.0%$10.33M+226%$3.17M-16.9%$3.81M—
Other intangible assets—net
$14.16M+21.8%$11.63M+121%$5.26M-10.2%$5.85M+8.7%
Other non-current assets
$7.27M+8.4%$6.71M+3,174%$205K+38.5%$148K-20.4%
Property, plant and equipment, net
$4.71M-20.7%$5.94M-14.8%$6.97M-11.2%$7.86M-14.3%
Software and Technology Licenses, Net
$7.27M+8.4%$6.71M+3,174%$205K+38.5%$148K-20.4%
Accrued Manufacturing Costs
$31.07M+31.3%$23.67M+5.9%$22.35M+7.2%$20.86M-11.6%
Accrued Rebates, Returns, and Promotions
$2.44M+22.4%$1.99M+81.6%$1.1M+66.3%$659K-16.4%
Other Commercial Liabilities
$11.38M+26.3%$9.01M-3.7%$9.36M-14.4%$10.93M+11.4%
Commissions and Contract Termination Costs
$5.39M+40.3%$3.84M-7.1%$4.14M+40.6%$2.94M+11.8%
Accrued Liabilities, Current
$11.38M+26.3%$9.01M-3.7%$9.36M-14.4%$10.93M+11.4%
Compensation and benefits
$31.07M+31.3%$23.67M+5.9%$22.35M+7.2%$20.86M-11.6%
Other accrued liabilities
$5.79M+28.5%$4.51M+55.7%$2.89M+57.8%$1.83M+17.2%
Professional Service Fees Payable
$978K+113%$459K-45.0%$834K-81.2%$4.45M+58.5%
Total debt
$22.53M-9.3%$24.84M-51.8%$51.55M-1.8%$52.47M-1.5%
Common Stock Par Value Per Share
$0.000.0%$0.000.0%$0.000.0%$0.000.0%
Common Stock Shares Issued
148.1M+0.8%146.9M+0.5%146.2M+28.6%113.7M+0.9%
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively
$148K+0.7%$147K+0.7%$146K+28.1%$114K+0.9%
Professional service fees
$978K+113%$459K-45.0%$834K-81.2%$4.45M+58.5%
Accrued rebates
$1.13M-7.6%$1.22M+64.2%$745K+5.4%$707K-47.4%
Allowance for doubtful accounts
$8.7M+178%$3.13M-0.4%$3.14M-16.9%$3.78M+219%
Common stock, par value (in dollars per share)
$00.0%$00.0%$00.0%$00.0%
Common stock, shares authorized (in shares)
$250M0.0%$250M0.0%$250M+33.3%$187.5M0.0%
Common stock, shares issued (in shares)
$148.09M+0.8%$146.93M+0.5%$146.23M+28.6%$113.71M+0.9%
Common Stock, Shares, Outstanding
$148.09M+0.8%$146.93M+0.5%$146.23M+28.6%$113.71M+1.6%
Customer refunds and credits
$2.44M+22.4%$1.99M+81.6%$1.1M+66.3%$659K-16.4%
Finite-Lived Intangible Assets, Accumulated Amortization
$24.21M+109%$11.59M+47.2%$7.87M+10.7%$7.11M—
Gross Carrying Amount
$37.32M+70.3%$21.92M+98.5%$11.04M+1.1%$10.92M—
Indefinite- lived intangible impairment
$38.36M+65.3%$23.22M+76.8%$13.13M+1.3%$12.96M+9.9%
Other accrued liabilities
$1.45M-3.1%$1.5M+92.2%$779K-20.2%$976K+60.8%
Number of product lines
————————

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are MiMedx Group's total assets?
MiMedx Group (MDXG) holds $308.7M in total assets, up 14.1% year over year.
How much debt does MiMedx Group have?
MiMedx Group carries $17.6M in total debt against $242.9M of shareholders' equity, a debt-to-equity ratio of 0.07.
How much cash does MiMedx Group have?
MiMedx Group holds $159.8M in cash and equivalents.
Can MiMedx Group cover its short-term obligations?
Its current ratio is 5.39 — current assets exceed current liabilities.
Where does MiMedx Group's balance sheet data come from?
Every line is extracted from MiMedx Group's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.